Home Antibody All anti-NR3C1 antibodies
Anti-NR3C1 PHOSPHO Antibody
Also for NR3C1 (NM_000176)
|The antiserum was produced against synthesized phosphopeptide derived from human GR around the phosphorylation site of serine 226 (L-L-SP-P-L).|
|Human, Mouse, Rat
||WB: 1:500~1:3000, IHC: 1:50~1:100, ELISA: 1:5000
|Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.|
|The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
|GR (Phospho-Ser226) antibody detects endogenous levels of GR only when phosphorylated at serine 226.
|Homo sapiens nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) (NR3C1), transcript variant 1|
|GCCR; GCR; GR; GRL|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of extracts from Jurkat cells, treated with EGF (200ng/ml, 15mins), using GR (Phospho-Ser226) antibody (#TA313371).The lane on the right is treated with the synthesized peptide.
Western blot analysis of extracts from 3T3 cells (Lane 2), using GR (Phospho-Ser226) Antibody. The lane on the left is treated with synthesized peptide.
Immunohistochemical analysis of paraffin-embedded human lung carcinoma tissue using GR (Phospho-Ser226) antibody (#TA313371).The picture on the right is treated with the synthesized peptide.